Roc, the G-domain of the Parkinson's disease-associated protein LRRK2.

Abstract excerpt

Mutation in leucine-rich repeat (LRR) kinase 2 (LRRK2) is a common cause of Parkinson's disease (PD). Aberrant LRRK2 kinase activity is associated with disease pathogenesis and thus it is an attractive drug target for combating PD. Intense efforts in the past nearly two decades have focused on the development of small-molecule inhibitors of the kinase domain of LRRK2 and have identified potent kinase inhibitors....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
• Share to Mutation
• Share to Parkinson Disease